New anticoagulants for secondary haemostasis - Anti IIa inhibitors;Neue antikoagulanzien der sekundären hämostase - Anti-IIa-inhibitoren

Hamostaseologie

Volumn 29, Issue 3, 2009, Pages 256-259

  Nowak, Götz ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Argatroban; Bivalirudin; Dabigatran; R hirudin; Thrombin inhibitor

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; AZD 0837; CLOPIDOGREL; DABIGATRAN; DABIGATRAN ETEXILATE; DESULFATOHIRUDIN; ENOXAPARIN; HEPARIN; HIRUDIN; HIRULOG; LEPIRUDIN; MELAGATRAN; PROTEINASE; THROMBIN INHIBITOR; UNCLASSIFIED DRUG; XIMELAGATRAN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING; BLOOD CLOTTING; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG METABOLISM; DRUG MONITORING; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; HEMATURIA; HEMOSTASIS; HUMAN; PLASMA PROTEIN BINDING; RESTENOSIS; REVIEW; SIDE EFFECT; STROKE; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS; THROMBOSIS PREVENTION;

EID: 68549087059     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1617034     Document Type: Review

References (7)

1. Eriksson BI, Dahl OE, Büller HR et al. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost 2005; 3: 103-111.
2. Lincoff AM, Bitte JA, Kleiman NS et al. The REPLACE 1 trial: a pilot study of bivalirudin versus heparin during percutaneous coronary intervention with stenting and GPIIbIIIa blockade. J Am Coll Cardiol 2002; 39: 16-17.
3. Lindhoff-Last E, Willeke A, Thalhammer C et al. Hirudin treatment in a breastfeeding woman. Lancet 2000; 355: 467-468.
4. Nowak G, Lange U, Bucha E. Drug monitoring of argatroban using the Ecarin Chromogenic Assay. Semin Thromb Hemost 2008; 34 (suppl 1): 81-86.
5. Serruys PW, Herrman JP, Simon R et al. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators. N Engl J Med 1995; 333: 757-763.
6. Stangier J, Rathgen K, Stähle H et al. The pharmacokinetics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. Br J Clin Pharmacol 2007; 64: 292-303. (Pubitemid 47283865)
7. Stone GW, McLaurin BT, Lox DA et al. Bivalirudin for patients with acute coronary syndromes. New Engl J Med 2006; 355: 2203-2216. (Pubitemid 44791162)